483
Gilead Sciences, Inc.Gilead Sciences, Inc. – FDA 483, Oct 18, 2011
Record Details
An FDA inspection of Gilead Sciences, Inc. in Foster City, CA, identified a significant issue regarding deviations from written sampling plans. The firm failed to record and justify these deviations, specifically concerning test method validation protocols for standard and sample solution expiration periods and planned changes in analyst and sample preparation evaluations. This indicates a lack of proper documentation and justification for critical testing procedures.
View Company Profile
ID · a5e41bd2-9af6-4c95-861c-759948bdb5c9
Other documents for Gilead Sciences, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.